EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets

Michael Fricker iD, Ravi Lokwani iD

Clinical Science · 22.10.2025 · 139 (20) · 1199-1214

DOI: 10.1042/cs20255452 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 22.10.2025. Verfasst von Michael Fricker und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Neutrophils, Inflammation, Lung. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophils are innate immune effector cells that play a vital role in host defense against infection. They exert antimicrobial activities through degranulation, phagocytosis, intracellular killing, production of reactive oxygen species, and neutrophil extracellular traps. Dysregulation of neutrophil abundance, phenotype, and immune activity is a commonly observed inflammatory feature of chronic obstructive pulmonary disease (COPD), a chronic inflammatory disorder of the lungs with no effective cure. Here, we review the clinical association and involvement of neutrophils in COPD pathogenesis, progression, and exacerbation. The association between neutrophilia, airway microbial imbalance (dysbiosis), and clinical manifestations of COPD is described. We summarize the impact (or lack of) of current treatments, including inhaled corticosteroids, macrolide antibiotics, and phosphodiesterase inhibitors, on neutrophilic inflammation or neutrophilia-associated features. Finally, we review potential future therapeutic options to address neutrophilic inflammation in COPD currently in clinical development, including anti-alarmins and inhibitors of neutrophil mediators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveNeutrophilsInflammationLungAnti-Inflammatory AgentsHumansAnimals

Stichwörter der Autor:innen

COPDextracellular trapsinflammationlungneutrophilproteasetherapeutics

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • School of Pharmacy, Chapman University, Irvine, California, U.S.A.

ORCID-Profile: Michael Fricker, Ravi Lokwani

Zitieren

APA

Fricker, M., & Lokwani, R. (2025). COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets. Clinical Science, 139(20), 1199-1214. https://doi.org/10.1042/cs20255452

Vancouver

Fricker M, Lokwani R. COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets. Clinical Science. 2025;139(20):1199-1214. doi:10.1042/cs20255452

BibTeX
@article{Fricker2025,
  author = {Fricker, Michael and Lokwani, Ravi},
  title = {COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {20},
  pages = {1199--1214},
  doi = {10.1042/cs20255452}
}
Kostenlos starten →